Literature DB >> 7629875

Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer.

J M Kolesar, J G Kuhn, H A Burris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7629875     DOI： 10.1093/jnci/87.13.1022-a

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

Review 1.  Benzene, NQO1, and genetic susceptibility to cancer.

Authors:  M T Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2.

Authors:  Casey M Clements; Richard S McNally; Brian J Conti; Tak W Mak; Jenny P-Y Ting
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

3.  Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies.

Authors:  Y Xu; J M Kolesar; L J Schaaf; R Drengler; W Duan; G Otterson; C Shapiro; J Kuhn; M A Villalona-Calero
Journal:  Cancer Chemother Pharmacol       Date:  2008-09-16       Impact factor: 3.333

Review 4.  Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.

Authors:  A Hirvonen
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

5.  Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

Authors:  R D Traver; D Siegel; H D Beall; R M Phillips; N W Gibson; W A Franklin; D Ross
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity.

Authors:  D Ross; R D Traver; D Siegel; B L Kuehl; V Misra; A M Rauth
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

7.  Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors.

Authors:  Xiumei Huang; Edward A Motea; Zachary R Moore; Jun Yao; Ying Dong; Gaurab Chakrabarti; Jessica A Kilgore; Molly A Silvers; Praveen L Patidar; Agnieszka Cholka; Farjana Fattah; Yoonjeong Cha; Glenda G Anderson; Rebecca Kusko; Michael Peyton; Jingsheng Yan; Xian-Jin Xie; Venetia Sarode; Noelle S Williams; John D Minna; Muhammad Beg; David E Gerber; Erik A Bey; David A Boothman
Journal:  Cancer Cell       Date:  2016-12-12       Impact factor: 38.585
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.